venBio Partners LLC

Q4 2024 13F Holdings

  • Location
    san francisco, CA
  • Num holdings

    7

  • Value ($000)

    $170,706

  • Date Filed
    02/14/2025
  • Form type
    13F-HR
  • CIK
    0001776382
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

PHARVARIS N V

COM
N69605108
$82.23M
48 %

4,289,304

ALMS
ALMS

ALUMIS INC

COM
022307102
$21.91M
13 %

2,787,398

HRMY
HRMY

HARMONY BIOSCIENCES HLDGS IN

COM
413197104
$18.55M
11 %

539,194

ALXO
ALXO

ALX ONCOLOGY HLDGS INC

COM
00166B105
$16.20M
10 %

9,699,925

---

ARTIVA BIOTHERAPEUTICS INC

COM
04317A107
$15.32M
9 %

1,519,971

---

ACELYRIN INC

COM
00445A100
$11.95M
7 %

3,806,410

LYEL
LYEL

LYELL IMMUNOPHARMA INC

COM
55083R104
$4.55M
3 %

7,102,190

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 7 of 7